WILLFUL IGNORANCE ON DISPLAY AT THE FDA?
Did the FDA ignore the WHO\u2019s damaging megastudy on Remdesivir to push through their full approval of the antiviral drug? Dr. Eric Topol, Founder and Director of the Scripps Research Institute and Professor of Molecular Medicine, thinks the expensive drug isn\u2019t that effective at all. Are safety and efficacy really the FDA\u2019s top concerns, or is there something else going on?